SaskPharm: a proposal for provincial drug production

Meili, Ryan
July 2011
CMAJ: Canadian Medical Association Journal;7/12/2011, Vol. 183 Issue 10, p1224
Academic Journal
The article discusses the proposed development of SaskPharm, a crown and pharmaceutical company that would produce generic drugs in Saskatchewan. It claims that SaskPharm would provide economic benefits to the province such as essential medicine to its population, creation of local jobs and money saving. It notes that SaskPharm would also offer jobs in research, medicine, information technology, commerce and other sectors.


Related Articles

  • Drug Makers Added 6% More Workers in Past Year. Reed, Vita // Orange County Business Journal;8/30/2010, Vol. 33 Issue 35, p21 

    The article reports on the capability of largest drug makers in Orange County, California to grow jobs nearly 6% according to the list of "Business Journal."

  • Ties that Bind.  // CA Magazine;Jan2003, Vol. 136 Issue 1, p11 

    Provides information on the evolution of the pharmaceutical industry in Canada. Competition between generic drug firms and brand-name drug firms; Monopoly period for brand-name pharmaceuticals in 1987; Stand of generic manufacturers with regard to patent laws in 1993.

  • Generics likely to rise on tide of expiring patents. Frederick, James // Drug Store News;10/8/2001, Vol. 23 Issue 15, p26 

    Looks at the improving economic outlook for the generic drug industry in the United States. Reasons behind the improving economic outlook; Significance of a loss of patent protection on key drug products for generic makers; Drugs with extended patent protection; Outlook of Doug Long, vice...

  • Education and promotion of generics might put the brakes on pharm costs. Nozar, Robert A. // Managed Healthcare Executive;Feb2002, Vol. 12 Issue 2, p36 

    Assesses the importance of generic drugs for pharmaceutical companies in the U.S. Development of prescription drugs; Success of Generic First program by Blue Cross Blue Shield of Michigan; Use of generic brand of drug for consumers.

  • Scorecard puts generics ahead so far this year. Ukens, Carol // Drug Topics;8/21/95 Generics Supplement, Vol. 139 Issue 16, p6S 

    Reports on the status of the United States generic pharmaceutical industry in 1994. Suggestions of Generic Pharmaceutical Industry Association president Lewis Engman on how to balance the federal medical care budget; Mergers and acquisitions among brand-name pharmaceutical companies; Financial...

  • Drugmakers readying for slew of drugs going off patent. Rosendahl, Iris // Drug Topics;8/21/95 Generics Supplement, Vol. 139 Issue 16, p44S 

    Discusses the implications for the generic drug industry of the patent or exclusivity expiration of over 150 major branded pharmaceutical products between 1995 and 2004. Products whose patents have expired but still have no generic competition; Opportunity for the generic industry to gain...

  • Generic leaders offer predictions for 1996. Breau, Joseph // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p6S 

    Presents a forum on the outlook of the generic drug industry in 1996. Effect on pharmacists; Forecasts for growth; Consolidation in the industry.

  • Strategic alliances: Less risky than marriage. Glaser, Martha // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p8S 

    Discusses the trend in strategic alliances among companies in the generic drug industry. Advantage of a strategic alliance over a merger; Generic market's potential; Justification for the arrangements.

  • How independent generic manufacturers will thrive. Muirhead, Greg // Drug Topics;11/20/95 Generics, Vol. 139 Issue 22, p26S 

    Discusses the outlook for independent generic drug manufacturers. Number of companies that would remain independent; Alliances in the industry; Strategies for independent companies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics